Infective Endocarditis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial
DiscussionThe DOTS trial will establish whether dalbavancin is superior to standard parenteral antibiotic therapy for the completion of treatment of complicatedS. aureus bacteremia.Trial registrationUS National Institutes of HealthClinicalTrials.govNCT04775953. Registered on 1 March 2021 (Source: Trials)
Source: Trials - May 16, 2022 Category: Research Source Type: clinical trials

ERAdicate S. Aureus in Patients With Bacteremia and Endocarditis
Conditions: Bacteremia Due to Staphylococcus Aureus; Left Sided Infective Endocarditis (Disorder); Right Sided Infective Endocarditis (Disorder); Endocarditis Infective Intervention: Drug: Tonabacase (LSVT-1701) Sponsor: Lysovant Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2022 Category: Research Source Type: clinical trials

Infective Endocarditis Surgery Using Conventional Prosthetic Valves Versus Cryopreserved Aortic Homograft
Conditions: Infective Endocarditis; Heart Failure Interventions: Procedure: Cryopreserved Aortic Homograft; Procedure: Stented/Non stented xenograft; Procedure: Mechanical prostheses Sponsors: Centre Cardiologique du Nord; Campus Bio-Medico University; Henri Mondor University Hospital; University of Genoa; University of Bristol; Aberdeen Royal Infirmary Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2022 Category: Research Source Type: clinical trials